Director of Pulmonary Hypertension (PH) and Right Heart Failure (RHF) Unit, Department of Cardiology, University of Copenhagen, Rigshospitalet. PI international research projects including randomized controlled studies and principal supervisor for three PhD-students as of 2017. Supervisor for more than twenty bachelor-, graduate- and PhD-degrees. First opponent University of Oslo, Norway, and faculty opponent University of Lund, Sweden. Scientific reviewer at National Science Foundation, USA and eight international peer reviewed journals. Speaker and chairman at several international conferences
 

Pulmonary hypertension (PH) and right heart failure (RHF), pulmonary embolism and lung transplantation  

DECIDE: The role of cardiac magnetic resonans imaging in assessment of right heart adaptation in pulmonary arterial hypertension; Acute high-risk pulmonary embolism – incidence, biomarkers, treatment and outcome. ASPIRE: arrhythmias in pulmonary arterial hypertension and right heart failure assessed by continuous long-term cardiac monitoring; Pulmonary hypertension in COPD: prevalence, predictors, and survival; Patient-specific model simulations in pulmonary arterial hypertension; Pathogenicity of genetic variants in pulmonary arterial hypertension; CONFRONT: cardiac magnetic resonance assessment in PAH. FREEDOM: A Phase III, international, multi-center, event driven study in PAH; TRITON: A multi-center, placebo-controlled, Phase 3b study on initial triple versus initial dual oral combination therapy in PAH.

Lecture, travel- and unrestricted research grant support